[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:muc1-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"MUC1 Gene",3,[7,15,21],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07612189","A Phase 1 Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors",[11],"Phase 1","RECRUITING","2026-08-26T02:18:42.501841Z","2026-05-29T15:36:40.230911Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT04020575","Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)",[11],"2026-08-26T02:15:46.655893Z","2026-05-05T02:43:28.902277Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT06483048","MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer",[11],"2026-08-26T02:19:05.360997Z","2026-05-05T02:43:28.503673Z"]